MoneyWorks4Me

Everest Organics - Quaterly Results

09 Aug 2022 Evaluate
A decrease in the sales to Rs. 430.28 millions was observed for the quarter ended June 2022. The sales stood at Rs. 513.29 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2022 is Rs. -27.55 millions as compared to Net Profit of Rs. 21.32 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -12.49% as compared to 43.43% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 430.28 513.29 -16.17 430.28 513.29 -16.17 2000.47 1815.67 10.18
Other Income 3.88 1.29 200.78 3.88 1.29 200.78 22.11 10.62 108.19
PBIDT -12.49 43.43 -128.76 -12.49 43.43 -128.76 86.39 239.05 -63.86
Interest 6.93 7.22 -4.02 6.93 7.22 -4.02 31.03 32.56 -4.70
PBDT -19.42 36.21 -153.63 -19.42 36.21 -153.63 55.36 206.49 -73.19
Depreciation 9.86 9.62 2.49 9.86 9.62 2.49 37.97 33.75 12.50
PBT -29.28 26.59 -210.12 -29.28 26.59 -210.12 17.39 172.74 -89.93
TAX -1.73 5.27 -132.83 -1.73 5.27 -132.83 5.96 35.59 -83.25
Deferred Tax -1.73 0.67 -358.21 -1.73 0.67 -358.21 3.06 5.39 -43.23
PAT -27.55 21.32 -229.22 -27.55 21.32 -229.22 11.43 137.15 -91.67
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) -2.90 8.46 -134.31 -2.90 8.46 -134.31 4.32 13.17 -67.20
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..